Lipocine Inc expected to post a loss of 3 cents a share - Earnings Preview

Lipocine

03/03/2023 17:14

* Lipocine Inc  LPCN.OQ   LPCN.O  is expected to show a fall
in
quarterly revenue when it reports  results on March 7
(estimated). 
    * The Salt Lake City Utah-based  company is expected to
report  a
91.9% decrease in revenue to $1.306 million from $16.09 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Lipocine Inc is for
a
loss of 3 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lipocine
Inc is
$4​, above​ its last closing price of $0.43. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.04       -0.03      -0.03     Met     10
 Jun. 30 2022  -0.04       -0.04      -0.03     Beat    25
 Mar. 31 2022  0.00        -0.02      -0.04     Missed  -100​
 Dec. 31 2021  0.07        -0.01      0.15      Beat    1,600
 ​​Sep.        -0.04       -0.04      -0.03     Beat    29.4
 30 2021                                                
 Jun. 30 2021  -0.05       -0.05      -0.03     Beat    40​
 Mar. 31 2021  -0.05       -0.05      -0.04     Beat    20
 Dec. 31 2020  -0.07       -0.06      -0.06     Met     5.3
 This summary was machine generated March 3 at 17:14 GMT.  All
figures in US dollars  unless otherwise stated